Skip to content
10-Q

Quarterly Report

NUNZIA PHARMACEUTICAL COMPANY

0001562884-21-000044

← back to feed
Filed
Sep 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Aug 10, 2021 256.12M sh
Stockholders Equity Q3 2020 · Sep 30, 2020 −$35.3K
Stockholders Equity Q3 2020 · Dec 31, 2019 −$22.58K
Current Liabilities Q3 2020 · Sep 30, 2020 $35.3K
Current Liabilities Q3 2020 · Dec 31, 2019 $22.58K
Total Assets Q3 2020 · Sep 30, 2020 $0
Total Assets Q3 2020 · Dec 31, 2019 $0
Operating Cash Flow Q3 2020 · Sep 30, 2019 $0
Sga Expense Q3 2020 · Sep 30, 2019 $1.31K
Sga Expense restated Q3 2020 · Sep 30, 2019 $24.87K
Net Income Q3 2020 · Sep 30, 2019 −$1.31K
Net Income restated Q3 2020 · Sep 30, 2019 −$24.87K
Net Income Q3 2020 · Jun 30, 2019 −$17.31K
Net Income Q3 2020 · Mar 31, 2019 −$6.26K
Operating Income Q3 2020 · Sep 30, 2019 −$1.31K
Operating Income restated Q3 2020 · Sep 30, 2019 −$24.87K
Revenue Q3 2020 · Sep 30, 2019 $0
Revenue Q3 2020 · Sep 30, 2019 $0